{"id":2903,"date":"2017-09-25T02:50:34","date_gmt":"2017-09-25T07:50:34","guid":{"rendered":"https:\/\/issels.com\/blog\/?p=2903"},"modified":"2017-09-25T06:18:26","modified_gmt":"2017-09-25T11:18:26","slug":"car-t-cells-may-be-an-effective-immunotherapy-for-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/issels.com\/blog\/2017\/09\/25\/car-t-cells-may-be-an-effective-immunotherapy-for-multiple-myeloma\/","title":{"rendered":"CAR T-Cells May Be an Effective Immunotherapy for Multiple Myeloma"},"content":{"rendered":"
\"Is
Is Issels Genomic Testing for Personalized Treatment For You?<\/figcaption><\/figure>\n

Researchers have been focusing on CAR T-cells as the basis for a promising immunotherapy cancer treatment<\/a>. Recent trials show encouraging results for the use of CAR T-cells in fighting advanced multiple myeloma<\/a>.<\/p>\n

CAR T Cells: A New Approach in Cancer Treatment<\/strong><\/p>\n

Scientists are excited about CAR T-cell therapy<\/a> because it uses a patient’s own immune cells to treat cancer. The cells are gathered from the patient’s blood, engineered to produce chimeric-antigen receptors (CARs), and multiplied in the lab to reach quantities in the billions.<\/p>\n

At that point, the cells are reintroduced into the patient’s bloodstream, to where they attach themselves to specific targets on cancer cells. CAR T-cell products, currently awaiting FDA approval, target the CD19 antigen in leukemia and lymphoma.<\/p>\n

Can CAR T-Cells Treat Different Cancers?<\/strong><\/p>\n

Two CAR T-cell trials were recently conducted in the United States and China. Results were presented last June at the annual meeting of the American Society of Clinical Oncology in Chicago.<\/p>\n

Both trials examined the use of CAR T-cells that target B-cell maturation antigens (BCMA), which are proteins found in myeloma cells<\/a>. Most of the patients in the studies achieved positive results, with many experiencing complete remission.<\/p>\n

CAR T-cell research is still in the early stages. Testing will continue to validate these findings and determine whether CAR T-cell therapy is a viable treatment method for cancer patients.<\/p>\n

Issels\u00ae: A Pioneer in Immunotherapy<\/strong><\/p>\n

We have a history of successful use of vaccines, NK cells<\/a> and other cancer treatment methods. Contact us<\/a> to learn more about why Issels\u00ae is the leader in personally developed immunotherapy programs.<\/p>\n","protected":false},"excerpt":{"rendered":"

Researchers have been focusing on CAR T-cells as the basis for a promising immunotherapy cancer treatment. Recent trials show encouraging results for the use of CAR T-cells in fighting advanced multiple myeloma. CAR T Cells: A New Approach in Cancer Treatment Scientists are excited about CAR T-cell therapy because it uses a patient’s own immune … Continue reading CAR T-Cells May Be an Effective Immunotherapy for Multiple Myeloma<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[203,580,537,205,216,538,1],"tags":[539,224,509,219],"class_list":["post-2903","post","type-post","status-publish","format-standard","hentry","category-cancer-research","category-cancer-treatment","category-cancer-vaccine","category-immuno-oncology","category-immunotherapy","category-immunotherapy-for-cancer","category-uncategorized","tag-cancer-immunotherapy","tag-cancer-treatment","tag-immuno-oncology","tag-immunotherapy"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/comments?post=2903"}],"version-history":[{"count":2,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2903\/revisions"}],"predecessor-version":[{"id":2911,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2903\/revisions\/2911"}],"wp:attachment":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/media?parent=2903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/categories?post=2903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/tags?post=2903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}